Just as remote working environments have become more and more popular, decentralized clinical trials (DCTs) have rapidly become more prevalent over the past few years as the need for more flexible trial models has remained steady. Traditionally, participants were required to travel to designated clinical trial sites in order to participate and be paid, but thanks to digital technologies, remote monitoring capabilities, and telemedicine, DCTs can now be completed virtually in the comfort of the participants’ own homes, a local health care facility, or even a nearby laboratory.
What began as a solution to pandemic-related challenges has now evolved into a transformative approach for clinical trial studies—one that’s poised to remain a key part of the industry. Now trial participants can take part in studies and receive payments without the added stress of traveling.
We know decentralized and virtual clinical trials are appealing, but what potential challenges and opportunities do they present when it comes to participant payments and compensation?
Decentralized Trial Participant Payment Challenges
As decentralized clinical trials continue to grow in popularity, they bring a more inclusive approach to participant recruitment and engagement. These trials enable individuals from diverse geographic locations, backgrounds, and demographics to participate without the need to travel to a central trial site. However, with this shift in trial structure comes the need for a rethinking of how payments and reimbursements are handled for participants. Traditional methods of compensating and reimbursing trial participants, such as paper checks, are becoming increasingly obsolete as more flexible, secure, and efficient alternatives are sought.
The reliance on paper checks presents several significant drawbacks, especially in the context of DCTs. First and foremost, checks are vulnerable to security risks, including loss, theft, or fraud. Since checks need to be physically handled and mailed, there is also a risk of delayed delivery, making it difficult to ensure timely compensation. This can lead to frustration among participants who may be relying on the payment for out-of-pocket expenses incurred during a trial or study. Additionally, for participants who do not have traditional bank accounts or access to physical locations where checks can be cashed, paper checks can pose an insurmountable barrier to timely reimbursement, undermining the inclusivity that DCTs aim to achieve.
DCT Participant Payment Opportunity
With these challenges in mind, the clinical trial industry has begun exploring digital payment solutions as a way to streamline the clinical trial compensation process. Digital payments, such as virtual prepaid payments that can be added to mobile wallets or ACH direct bank transfers can offer much faster and more secure alternatives to paper checks. These methods also eliminate many of the logistical hurdles associated with traditional payment methods. For instance, participants can receive funds near-instantly, regardless of their location, and without the need to visit a physical bank. Moreover, digital payment options for clinical trials can be set up with trial sponsors’, trial sites’, and site networks’ needs in mind or integrated with clinical trial management platforms, making the payment and reimbursement process more secure, automated, and transparent.
In addition to speed and security, these digital methods help to overcome some of the financial barriers that certain participant populations might face. For participants who may not have a traditional bank account, digital prepaid debit cards provide a practical alternative to paper checks. These payment methods can be particularly beneficial for participants in underbanked or rural areas, where access to physical banking infrastructure is limited. By embracing these more inclusive payment systems, decentralized clinical trial sponsors, networks, and sites can ensure that all participants, regardless of their financial situation or geographic location, have equal access to payments and reimbursements.
As the landscape of clinical trials continues to evolve with technology and virtual options, the payment models must adapt to meet the needs of a more diverse participant pool. This shift from paper checks to digital payments not only enhances security and convenience but also reflects a broader commitment to making clinical trials more accessible and inclusive for all participants. The move towards digital payments in decentralized clinical trials marks a significant step toward modernizing the clinical trial experience, increasing payment security, reducing barriers to participation, and improving the overall efficiency of trial operations.
Learn more about participant payments for decentralized clinical trials
